Wondering why Teriparatide (Forteo) is so hard to find at pharmacies? Learn the reasons behind availability issues and what you can do to get your prescription filled in 2026.
You've got a prescription for Teriparatide — also sold under the brand name Forteo — and you're ready to start treating your osteoporosis. But when you call your pharmacy, they don't have it. You try another one. Same story. What's going on?
Teriparatide is a critical medication for people at high risk of bone fractures, but finding it in stock can feel like a scavenger hunt. In this guide, we'll break down exactly why Teriparatide is so hard to find in 2026 and what you can do about it.
Teriparatide is an injectable medication that belongs to a class of drugs called parathyroid hormone analogs. It's a lab-made version of the first 34 amino acids of human parathyroid hormone (PTH). Unlike most osteoporosis drugs that simply slow down bone loss, Teriparatide actually builds new bone, making it one of the most powerful treatments available for severe osteoporosis.
The brand-name version, Forteo, has been on the market since 2002. Generic versions from manufacturers like Teva and Alvogen are now available as well. It's given as a once-daily injection using a prefilled pen and is typically prescribed for up to two years.
There are several reasons you might be having trouble getting your hands on this medication:
Teriparatide isn't something your corner pharmacy keeps on the shelf next to ibuprofen. It's classified as a specialty medication, which means it requires special handling — including cold chain storage (it must be refrigerated). Many retail pharmacies simply don't stock it because the demand at any single location is low and the logistics are complicated.
Most insurance plans — including Medicare Part D — require prior authorization before they'll cover Teriparatide. Many also require step therapy, meaning your doctor has to document that you've tried and failed cheaper treatments like bisphosphonates (Alendronate, Risedronate) before the insurer will approve Teriparatide. This process can take days or even weeks, creating delays that feel like a supply problem.
Because it's a specialty drug, Teriparatide is often only available through specialty pharmacies — not your typical CVS or Walgreens. Your insurance plan may even require you to use a specific specialty pharmacy, which can add shipping time and coordination challenges.
In early 2025, Eli Lilly made changes to the Forteo pen labeling and packaging. While this wasn't a true supply shortage, it caused temporary confusion at pharmacies with billing and dispensing. Some of those ripple effects can still make it harder to locate the medication at certain locations.
If you're struggling to find Teriparatide, here are some practical steps:
Medfinder lets you search for pharmacies that currently have Teriparatide in stock near you. Instead of calling pharmacy after pharmacy, you can check availability in one place. It's free and updated regularly.
If your pharmacy can't get brand-name Forteo, ask about the generic version. FDA-approved generic teriparatide injections are available from Teva and other manufacturers. They use the same formulation and are typically significantly cheaper — with GoodRx coupons, generic teriparatide can cost as little as $1,146 per pen compared to over $3,100 for brand Forteo.
If your local pharmacy doesn't carry Teriparatide, ask your doctor's office to connect you with a specialty pharmacy. These pharmacies specialize in medications like Teriparatide and can ship it directly to your home with proper cold packing.
If insurance delays are the bottleneck, make sure your prescriber's office has submitted the prior authorization. Ask them to follow up with the insurance company directly. If you've been denied, you may be able to use discount programs or patient assistance to access the medication while you appeal.
If Teriparatide is truly unavailable or unaffordable for your situation, there are other osteoporosis medications your doctor might consider, including Abaloparatide (Tymlos), Romosozumab (Evenity), and Denosumab (Prolia).
Teriparatide is a genuinely important medication — it's one of the few drugs that actually builds new bone rather than just slowing bone loss. Finding it shouldn't be this hard, but between specialty pharmacy logistics, insurance red tape, and distribution quirks, it often is.
The good news: with the right tools and a little persistence, most patients can get their prescription filled. Start with Medfinder to find pharmacies with Teriparatide in stock near you, and don't hesitate to ask your healthcare team for help navigating the process.
For more details on what's happening with Teriparatide supply, check out our 2026 shortage update.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
